Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

Carrier screening for cystic fibrosis: costs and clinical outcomes.

Asch DA, Hershey JC, Dekay ML, Pauly MV, Patton JP, Jedrziewski MK, Frei F, Giardine R, Kant JA, Mennuti MT.

Med Decis Making. 1998 Apr-Jun;18(2):202-12.

PMID:
9566453
2.

The cost-effectiveness of prenatal carrier screening for cystic fibrosis.

Lieu TA, Watson SE, Washington AE.

Obstet Gynecol. 1994 Dec;84(6):903-12.

PMID:
7970468
3.

[Preconception screening of parents and carrier state of cystic fibrosis in the Netherlands: expenses and savings].

Verheij JB, Hilderink HB, Verzijl JG, Wildhagen MF, Habbema JD, ten Kate LP.

Ned Tijdschr Geneeskd. 1998 Mar 28;142(13):706-10. Dutch.

PMID:
9623144
4.

Informing policy for the Australian context - Costs, outcomes and cost savings of prenatal carrier screening for cystic fibrosis.

Maxwell S, Brameld K, Youngs L, Geelhoed E, O'Leary P.

Aust N Z J Obstet Gynaecol. 2010 Feb;50(1):51-9. doi: 10.1111/j.1479-828X.2009.01111.x.

PMID:
20218998
5.

Cost effectiveness of antenatal screening for cystic fibrosis.

Cuckle HS, Richardson GA, Sheldon TA, Quirke P.

BMJ. 1995 Dec 2;311(7018):1460-3; discussion 1463-4. Erratum in: BMJ 1995 Dec 16;311(7020):1608.

6.

Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.

Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB.

Pediatrics. 2004 Jun;113(6):1573-81.

PMID:
15173476
7.

Prenatal screening for cystic fibrosis carriers: an economic evaluation.

Rowley PT, Loader S, Kaplan RM.

Am J Hum Genet. 1998 Oct;63(4):1160-74.

8.

Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.

Massie J, Forbes R, Dusart D, Bankier A, Delatycki MB.

J Paediatr Child Health. 2007 Nov;43(11):721-3.

PMID:
17924936
9.

Cystic fibrosis carrier population screening in the primary care setting.

Loader S, Caldwell P, Kozyra A, Levenkron JC, Boehm CD, Kazazian HH Jr, Rowley PT.

Am J Hum Genet. 1996 Jul;59(1):234-47.

10.

Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling.

Mischler EH, Wilfond BS, Fost N, Laxova A, Reiser C, Sauer CM, Makholm LM, Shen G, Feenan L, McCarthy C, Farrell PM.

Pediatrics. 1998 Jul;102(1 Pt 1):44-52.

PMID:
9651412
11.

Planning the development of cystic fibrosis gene carrier screening.

Beech R, Bekker H.

J Health Serv Res Policy. 1996 Apr;1(2):81-92.

PMID:
10180854
12.

A cost-effectiveness analysis of prenatal carrier screening for cystic fibrosis.

Vintzileos AM, Ananth CV, Smulian JC, Fisher AJ, Day-Salvatore D, Beazoglou T.

Obstet Gynecol. 1998 Apr;91(4):529-34.

PMID:
9540935
13.

Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.

Massie J, Petrou V, Forbes R, Curnow L, Ioannou L, Dusart D, Bankier A, Delatycki M.

Aust N Z J Obstet Gynaecol. 2009 Oct;49(5):484-9. doi: 10.1111/j.1479-828X.2009.01045.x.

PMID:
19780730
14.

Outcomes of a cystic fibrosis carrier testing clinic for couples.

Christie LM, Ingrey AJ, Turner GM, Proos AL, Watts GE.

Med J Aust. 2009 Nov 2;191(9):499-501.

PMID:
19883345
15.

Costs, effects, and savings of screening for cystic fibrosis gene carriers.

Wildhagen MF, Hilderink HB, Verzijl JG, Verheij JB, Kooij L, Tijmstra T, ten Kate LP, Habbema JD.

J Epidemiol Community Health. 1998 Jul;52(7):459-67.

16.

Cost-effectiveness of carrier screening for cystic fibrosis in Australia.

Norman R, van Gool K, Hall J, Delatycki M, Massie J.

J Cyst Fibros. 2012 Jul;11(4):281-7. doi: 10.1016/j.jcf.2012.02.007. Epub 2012 Mar 16.

17.

Cost-benefit analysis of a national screening programme for cystic fibrosis in an Israeli population.

Ginsberg G, Blau H, Kerem E, Springer C, Kerem BS, Akstein E, Greenberg A, Kolumbos A, Abeliovich D, Gazit E, et al.

Health Econ. 1994 Jan-Feb;3(1):5-23.

PMID:
8167800
18.

Is cystic fibrosis carrier screening cost effective?

Wei S, Quigg MH, Monaghan KG.

Community Genet. 2007;10(2):103-9.

PMID:
17380060
19.

Screening for cystic fibrosis and its evaluation.

Wildhagen MF, ten Kate LP, Habbema JD.

Br Med Bull. 1998;54(4):857-75. Review.

20.

Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.

Ciske DJ, Haavisto A, Laxova A, Rock LZ, Farrell PM.

Pediatrics. 2001 Apr;107(4):699-705.

PMID:
11335747
Items per page

Supplemental Content

Write to the Help Desk